Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice-Reference-Cited by-同舟云学术

Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice

Published:2014-11-10 Issue:3 Volume:86 Page:243-243
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:Journal of Neurology, Neurosurgery & Psychiatry

Author:

Aktas O.

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference5 articles.

1. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more;Mayer;Ther Adv Neurol Disord,2012

2. The spectrum of MOG autoantibody-associated demyelinating diseases;Reindl;Nat Rev Neurol,2013

3. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein;Baumann;J Neurol Neurosurg Psychiatry

4. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype;Kitley;Neurology,2012

5. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders;Sato;Neurology,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution in anti-myelin oligodendrocyte glycoprotein antibody detection and its clinical significance: a narrative review;Annals of Translational Medicine;2021-01

2. A prospective, observational study on conversion of clinically isolated syndrome to multiple sclerosis during 4-year period (MS NEO study) in Taiwan;PLOS ONE;2019-07-15

3. Different features between pediatric-onset and adult-onset patients who are seropositive for MOG-IgG: A multicenter study in South China;Journal of Neuroimmunology;2018-08

4. Diagnose der Multiplen Sklerose: Revision der McDonald-Kriterien 2017;Der Nervenarzt;2018-06-06

5. Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies;Multiple Sclerosis and Related Disorders;2017-11